This article is part of the Diversity & Dementia series, produced by Being Patient with support provided by Eisai. When a loved one has…
When entrepreneur Eben Pingree’s mother, 78, and father-in-law, 80, were both diagnosed with Alzheimer’s in the same week about two years ago, it shook…
In late September 2024, Hurricane Helene caused widespread damage and loss of power across the Southeastern United States, with western regions of North Carolina…
It’s that time of year again – the end of daylight savings and the beginning of the dark season. While many of us look…
Although cigarette smoking has declined for decades in the U.S., electronic cigarettes, also called vapes, have gained popularity in recent years. Now, almost one…
When was the last time you got your vision checked? Routine screenings could spot cataracts and other eye diseases early, keeping vision loss minimal….
VR has been a fixture in entertainment technology for years now, allowing people to experience almost life-like simulations through portable and easy-to-use headsets. Now,…
A dementia diagnosis can change everyday life significantly for the person diagnosed and their caregivers. For people living with dementia, tasks that once felt…
Caregivers: If you’re constantly worrying or feeling anxious, overwhelmed or moody, if you have difficulty concentrating, if you’re depressed or agitated, if your self…
Since Leqembi was approved in the U.S. in the summer of 2023, controversy has roiled among clinicians over whether the Alzheimer’s anti-amyloid drug’s risks…
This article is part of the Diversity & Dementia series, produced by Being Patient with support provided by Eisai. Black Americans have nearly double…
You receive a text message from an unknown number: “I wrote this memo just for you and I really need you to take a…
This past three months in the Alzheimer’s drug development space have seen a new FDA approval for a symptomatic treatment, a couple failed phase…
Bob Toia, 77, had a career in drug research, developing clinical trials for new drug entities at Proctor and Gamble. During those years, he…
At the 2024 Clinical Trials on Alzheimer’s Disease (CTAD) conference in Madrid, Spain, scientists and drug development companies gathered to report on recent successes…